Vyzulta is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Latanoprostene Bunod.
| Product ID | 24208-504_06204573-97d3-4253-8685-87273ea08d58 | 
| NDC | 24208-504 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Vyzulta | 
| Generic Name | Latanoprostene Bunod | 
| Dosage Form | Solution/ Drops | 
| Route of Administration | OPHTHALMIC | 
| Marketing Start Date | 2017-11-02 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA207795 | 
| Labeler Name | Bausch & Lomb Incorporated | 
| Substance Name | LATANOPROSTENE BUNOD | 
| Active Ingredient Strength | 0 mg/mL | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2018-06-11 | 
| NDC Exclude Flag | N | 
| Sample Package? | Y | 
| Marketing Category | NDA | 
| Application Number | NDA207795 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-11-02 | 
| Marketing Category | NDA | 
| Application Number | NDA207795 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2018-06-11 | 
| Marketing Category | NDA | 
| Application Number | NDA207795 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2018-06-11 | 
| Marketing Category | NDA | 
| Application Number | NDA207795 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2017-11-02 | 
| Ingredient | Strength | 
|---|---|
| LATANOPROSTENE BUNOD | .24 mg/mL | 
| SPL SET ID: | 60ce7900-a677-4fc2-88d0-1603baa9dbd4 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  VYZULTA  87474310  not registered Dead/Abandoned | Bausch & Lomb Incorporated 2017-06-04 | 
|  VYZULTA  87473150  5525995 Live/Registered | Bausch & Lomb Incorporated 2017-06-02 | 
|  VYZULTA  86111055  not registered Dead/Abandoned | Bausch & Lomb Incorporated 2013-11-05 |